Skip to content

Clinical trials

alpha 1-Antitrypsin Deficiency trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: alpha 1-Antitrypsin Deficiency Country / region: Belgium Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20191
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda2
Centre Hospitalier Universitaire de Liege1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Kamada, Ltd.1
Mereo BioPharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
alpha 1-Antitrypsin Deficiency6
Adrenal Hyperplasia, Congenital1
Adrenoleukodystrophy1
Andersen Syndrome1
Anemia, Diamond-Blackfan1
Anemia, Sickle Cell1
Argininosuccinic Aciduria1
Aspartylglucosaminuria1
Biotinidase Deficiency1
Carbamoyl-Phosphate Synthase I Deficiency Disease1

Trials

Showing 51 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.